Allmed Solutions Ltd Stock

Equities

ALMD

IL0011014508

Medical Equipment, Supplies & Distribution

Market Closed - TEL AVIV STOCK EXCHANGE 10:24:32 2024-07-17 am EDT 5-day change 1st Jan Change
38.3 ILa 0.00% Intraday chart for Allmed Solutions Ltd -1.29% +2.96%

Financials

Sales 2022 - Sales 2023 - Capitalization 40.22M 11.07M 4.02B
Net income 2022 -12M -3.3M -1.2B Net income 2023 1M 275K 100M EV / Sales 2022 -
Net cash position 2022 20.36M 5.61M 2.04B Net cash position 2023 56.23M 15.48M 5.62B EV / Sales 2023 -
P/E ratio 2022
-1.78 x
P/E ratio 2023
28.3 x
Employees 19
Yield 2022 *
-
Yield 2023
-
Free-Float 63.87%
More Fundamentals * Assessed data
Dynamic Chart
1 week-1.29%
Current month+13.31%
1 month+21.97%
3 months-9.24%
6 months+0.26%
Current year+2.96%
More quotes
1 week
37.90
Extreme 37.9
38.50
1 month
32.20
Extreme 32.2
39.80
Current year
31.00
Extreme 31
47.50
1 year
31.00
Extreme 31
47.50
3 years
24.20
Extreme 24.2
94.90
5 years
24.20
Extreme 24.2
94.90
10 years
24.20
Extreme 24.2
324.70
More quotes
Managers TitleAgeSince
Chief Executive Officer 68 22-02-28
Director/Board Member 54 12-09-30
Comptroller/Controller/Auditor 38 21-10-16
Members of the board TitleAgeSince
Founder 68 04-01-03
Director/Board Member 54 12-09-30
Director/Board Member 55 22-08-02
More insiders
Date Price Change Volume
24-07-17 38.3 0.00% 15,000
24-07-16 38.3 +0.26% 31,299
24-07-15 38.2 0.00% 2,597
24-07-14 38.2 -1.55% 16,001
24-07-11 38.8 0.00% 2,348

Delayed Quote TEL AVIV STOCK EXCHANGE, July 17, 2024 at 10:24 am EDT

More quotes
Allmed Solutions Ltd, former Allium Medical Solutions Ltd, is an Israel-based company, which develops, manufactures and markets minimally invasive products internationally. Its products are used by physicians to treat a number of diseases and patients worldwide. The Company's product lines include: Covered Stents, which offers Ureteral Stent (URS), Round Posterior Stent (RPS), Triangular Prostatic Stent (TPS), Bulbar Stent (BUS) and Biliary Stent (BIS); Uro-Gynecology, which offers EndoFast Reliant System, EndoFast Resorb, EndoFast Reliant MN and EndoFast Reliant SCP; Type II Diabetes, which offers the Gastro-duodenal sleeve (GDS), as well as Cardiovascular, which offers WIRION EPD System. The Company's products serve patients with the following medical conditions: Pelvic Organ Prolapse (POP), Sacrocolpopexy, Male Stress Urinary Incontinence (SUI), Urethral/Ureteral Stricture, Carotid Stenosis, Biliary Stricture and Type II Diabetes.
More about the company